Teva price target raised to $30 from $28 at UBS
UBS raised the firm’s price target on Teva (TEVA) to $30 from $28 and keeps a Buy rating on the shares. Teva, one of the firm’s top picks for ...
FiercePharma23h
Teva's multiple sclerosis stalwart Copaxone gets FDA boxed warning for anaphylaxis risk
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
The Best Slip-On Shoes For Men Who Are Just Done With Shoelaces
Merrell's Jungle Mocs are a recognizable favorite slip-on that boasts an EVA foam midsole and air-cushioned heel that absorbs ...
ENDPOINTS NEWS23h
Te­va’s MS drug and gener­ics to add black box warn­ing for ana­phy­lax­is
FDA adds boxed warning to Teva's Copaxone and generic versions after serious allergic reactions, including anaphylaxis that ...
Walmart Is Packed with Walking, Slip-On, and Training Shoes from Reebok, Avia, and More — All $25 and Under
And we found the best styles — all $25 and under. Its wide selection includes top brands like Reebok and Avia, with styles such as slip-ons, walking sneakers, training shoes, and more. Thousands of ...
lifesciencesipreview18h
Fed Circ grants Teva temporary pause in Orange Book feud
Teva insisted panel’s narrow interpretation of ‘claims the drug’ will have a seismic effect on the Orange Book | Stay granted while en banc rehearing is under question | Decision could reshape patent ...